Skip to main content
. 2018 Jan 4;26(3):917–931. doi: 10.1016/j.ymthe.2017.12.022

Figure 1.

Figure 1

Incidence of Infections in Three or More Patients by Study Phase

Incidence rate calculations include patients who resumed PEG-ADA treatment due to a lack of GT efficacy. In any given phase, only those AEs that were new or worsened after the start of a particular phase were reported.